FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Chemcon IPO and Gland Pharma IPO.
Chemcon IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Gland Pharma IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Chemcon IPO | Gland Pharma IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Ambit Private Limited Intensive Fiscal Services Private Limited |
Citigroup Global Markets India Private Limited Haitong Securities India Private Limited Kotak Mahindra Capital Company Limited Nomura Financial Advisory And Securities (India) Pvt Ltd |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Chemcon IPO is up to ₹318.00 Cr whereas the issue size of the Gland Pharma IPO is up to ₹6,479.55 Cr. The final issue price of Chemcon IPO is ₹340.00 per share and of Gland Pharma IPO is ₹1,500.00 per share.
Chemcon IPO | Gland Pharma IPO | |
---|---|---|
Face Value | ₹10 per share | ₹1 per share |
Issue Price (Lower) | ₹338.00 per share | ₹1,490.00 per share |
Issue Price (Upper) | ₹340.00 per share | ₹1,500.00 per share |
Issue Price (Final) | ₹340.00 per share | ₹1,500.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 44 shares | 10 shares |
Fresh Issue Size | 48,52,940 shares | 83,33,333 shares |
Fresh Issue Size (Amount) | up to ₹165.00 Cr | up to ₹1,250.00 Cr |
OFS Issue Size | 45,00,000 shares | 3,48,63,635 shares |
OFS Issue Size (Amount) | up to ₹153.00 Cr | up to ₹5,229.55 Cr |
Issue Size Total | 93,52,940 shares | 4,31,96,968 shares |
Issue Size Total (Amount) | up to ₹318.00 Cr | up to ₹6,479.55 Cr |
Chemcon IPO opens on Sep 21, 2020, while Gland Pharma IPO opens on Nov 09, 2020. The closing date of Chemcon IPO and Gland Pharma IPO is Sep 23, 2020, and Nov 11, 2020, respectively.
Chemcon IPO | Gland Pharma IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Sep 21, 2020 | Nov 09, 2020 |
Issue Close | Sep 23, 2020 | Nov 11, 2020 |
Basis Of Allotment (Tentative) | Sep 28, 2020 | Nov 17, 2020 |
Initiation of Refunds (Tentative) | Sep 29, 2020 | Nov 18, 2020 |
Credit of Share (Tentative) | Sep 30, 2020 | Nov 19, 2020 |
Listing date (Tentative) | Oct 01, 2020 | Nov 20, 2020 |
Anchor Lockin End date 1 | Oct 28, 2020 | Dec 17, 2020 |
Anchor Lockin End date 2 | Dec 27, 2020 | Feb 15, 2021 |
Chemcon IPO P/E ratio is , as compared to Gland Pharma IPO P/E ratio of .
Chemcon IPO | Gland Pharma IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100% | 74% | |||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 74.47% | 58% | |||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | |||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | |||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Chemcon IPO retail investors (RII) are offered 32,83,580 shares while in Gland Pharma IPO retail investors are offered 32,83,580 shares. Qualified institutional buyers (QIB) are offered 18,68,344 shares in Chemcon IPO and 86,39,394 shares in Gland Pharma IPO.
Chemcon IPO | Gland Pharma IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 18,68,344 shares | 86,39,394 shares |
NII | 14,07,249 shares | 64,79,546 shares |
RII | 32,83,580 shares | 1,51,18,939 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 65,59,173 shares | 3,02,37,879 shares |
Chemcon IPO subscribed 149.30x in total, whereas Gland Pharma IPO subscribed 2.06x.
Chemcon IPO | Gland Pharma IPO | |
---|---|---|
QIB (times) | 113.54x | 6.40x |
NII (times) | 449.14x | 0.51x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 41.15x | 0.24x |
Employee (times) | ||
Other (times) | ||
Total (times) | 149.30x | 2.06x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|